Equillium (Germany) Today

0FY Stock  EUR 0.72  0.04  5.26%   

Performance

Insignificant

 
Weak
 
Strong

Odds Of Distress

Average

 
High
 
Low
Equillium is trading at 0.72 as of the 26th of February 2025. This is a 5.26 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.72. Equillium has over 55 % chance of experiencing financial distress in the next 2 years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 27th of January 2025 and ending today, the 26th of February 2025. Click here to learn more.
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California. The company has 34.41 M outstanding shares. More on Equillium

Moving against Equillium Stock

  0.45CSJ CSL LimitedPairCorr
  0.440QF ModernaPairCorr
  0.42CSJA CSL LTD SPONADRPairCorr
  0.42BUU DevEx ResourcesPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Equillium Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Equillium's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Equillium or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOBruce Steel
Business ConcentrationBiotechnology, Healthcare (View all Sectors)
Equillium (0FY) is traded on Frankfurt Exchange in Germany and employs 45 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 35.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Equillium's market, we take the total number of its shares issued and multiply it by Equillium's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Equillium classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 34.41 M outstanding shares. Equillium has accumulated about 82.16 M in cash with (32.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.83, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Equillium Probability Of Bankruptcy
Ownership Allocation
Equillium holds a total of 34.41 Million outstanding shares. Equillium retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Equillium Ownership Details

Equillium Risk Profiles

Although Equillium's alpha and beta are two of the key measurements used to evaluate Equillium's performance over the market, the standard measures of volatility play an important role as well.

Equillium Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Equillium without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module

Equillium Corporate Executives

Elected by the shareholders, the Equillium's board of directors comprises two types of representatives: Equillium inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Equillium. The board's role is to monitor Equillium's management team and ensure that shareholders' interests are well served. Equillium's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Equillium's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jason KeyesChief Financial OfficerProfile

Additional Information and Resources on Investing in Equillium Stock

When determining whether Equillium is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Equillium Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Equillium Stock. Highlighted below are key reports to facilitate an investment decision about Equillium Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Equillium. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Equillium Stock please use our How to Invest in Equillium guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.